News Story: Full Text
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

 

NYU Langone Health launches new molecular assay to identify patients with brain tumors

Al's Comment:

 This is a new type of testing - which is a little more advanced than just seeing which genes are present or mutated. This tells which genes are active and may be able to better tell which patients might benefit from particular medications than just using the genetic profiling.


Posted on: 10/26/2019

NYU Langone Health launches new molecular assay to identify patients with brain tumors

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740